These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of fatty acid regulation on visfatin gene expression in adipocytes. Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017 [TBL] [Abstract][Full Text] [Related]
23. Speciation of potential anti-diabetic vanadium complexes in real serum samples. Sanna D; Ugone V; Serra M; Garribba E J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Solution by EPR Spectroscopy. Hanson GR; Sun Y; Orvig C Inorg Chem; 1996 Oct; 35(22):6507-6512. PubMed ID: 11666798 [TBL] [Abstract][Full Text] [Related]
25. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats. Sakurai H; Sano H; Takino T; Yasui H J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469 [TBL] [Abstract][Full Text] [Related]
26. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds. Crans DC J Inorg Biochem; 2000 May; 80(1-2):123-31. PubMed ID: 10885472 [TBL] [Abstract][Full Text] [Related]
27. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice. Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032 [TBL] [Abstract][Full Text] [Related]
28. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent. Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988 [TBL] [Abstract][Full Text] [Related]
29. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis. Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406 [TBL] [Abstract][Full Text] [Related]
30. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro]. Li YR; Gao LH; Ma YL; Niu YF; Liu WP; Li L Yao Xue Xue Bao; 2008 Mar; 43(3):318-22. PubMed ID: 18630272 [TBL] [Abstract][Full Text] [Related]
31. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes. Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the binding of oxovanadium(IV) to human serum albumin. Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413 [TBL] [Abstract][Full Text] [Related]
34. Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G. Sanna D; Micera G; Garribba E Inorg Chem; 2011 Apr; 50(8):3717-28. PubMed ID: 21434616 [TBL] [Abstract][Full Text] [Related]
35. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes. Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643 [TBL] [Abstract][Full Text] [Related]
36. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat. Yasui H; Adachi Y; Katoh A; Sakurai H J Biol Inorg Chem; 2007 Aug; 12(6):843-53. PubMed ID: 17503093 [TBL] [Abstract][Full Text] [Related]
37. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans. D'Cruz OJ; Dong Y; Uckun FM Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012 [TBL] [Abstract][Full Text] [Related]
38. Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum. Kiss T; Kiss E; Garribba E; Sakurai H J Inorg Biochem; 2000 May; 80(1-2):65-73. PubMed ID: 10885465 [TBL] [Abstract][Full Text] [Related]
39. New oxovanadium bis(1,2-dithiolate) compounds that mimic the hydrogen-bonding interactions at the active sites of mononuclear molybdenum enzymes. Cooney JJ; Carducci MD; McElhaney AE; Selby HD; Enemark JH Inorg Chem; 2002 Dec; 41(26):7086-93. PubMed ID: 12495349 [TBL] [Abstract][Full Text] [Related]
40. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities. Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]